Clinical Trial Survey
Are you living with hepatitis B and interested in guiding future clinical trials for new hepatitis B medicines? Would you like to share your thoughts about current and future clinical trials for hepatitis B? The Hepatitis B Foundation is interested in learning more about your opinion, beliefs and perspectives on participation in clinical trials for new hepatitis B medicines.
Your responses to our anonymous online survey will help inform policy makers and drug developers about how to improve the diversity of participants in clinical trials and eliminate barriers to participation. This will ultimately improve the safety and effectiveness of future hepatitis B medicines. We need as many people as possible to complete the survey to have robust information and recommendations to share with the FDA about how clinical trials can be more inclusive, leaving no one behind.
All responses will be kept anonymous and confidential. The information we share with the FDA will only be presented as a summary.
The 20-minute survey is available in English, French, Tagalog, Marshallese, Mandarin, Vietnamese, Korean, Spanish and Amharic. If you are interested in sharing your opinion, please use this link to participate in the survey. If you have any questions, please email email@example.com, and one of our team members will be happy to answer your questions.
Thank you so much in advance for your help!